Accès à distance ? S'identifier sur le proxy UCLouvain
Long-term safety of infliximab (INX) with methotrexate (MTX) in a large belgian observational patient cohort with severe, refractory rheumatoid arthritis (RA)
Primary tabs
| Document type | Communication à un colloque (Conference Paper) – Abstract, Présentation orale avec comité de sélection |
|---|---|
| Publication date | 2006 |
| Language | Anglais |
| Conference | "Annual European Congress of Rheumatology (EULAR 2006)", Amsterdam (Netherlands) (Jun 21-24, 2006) |
| Journal information | "Annals of the Rheumatic Diseases" - Vol. 65, p. 189-189 (2006) |
| Peer reviewed | yes |
| issn | 0003-4967 |
| e-issn | 1468-2060 |
| Publisher | B M J Publishing Group (London) |
| Affiliations |
UCL
- Cliniques universitaires Saint-Luc UCL - MD/MINT - Département de médecine interne |
| Links |
| Bibliographic reference | Durez, Patrick ; Devogelaer, Jean-Pierre ; Vander Cruyssen, B. ; Vandenbosch, F. ; Vastesaeger, N. ; et. al. Long-term safety of infliximab (INX) with methotrexate (MTX) in a large belgian observational patient cohort with severe, refractory rheumatoid arthritis (RA).Annual European Congress of Rheumatology (EULAR 2006) (Amsterdam (Netherlands), Jun 21-24, 2006). In: Annals of the Rheumatic Diseases, Vol. 65, p. 189-189 (2006) |
|---|---|
| Permanent URL | http://hdl.handle.net/2078.1/59552 |